ALLERGEN SPECIFIC IMMUNOTHERAPY
Keywords:
immunotherapy, pollen allergy, allergoidAbstract
Allergen-specific immunotherapy (ASIT) is the only disease-modifying therapy for IgE-mediated allergic diseases (allergic rhinitis, allergic conjunctivitis, allergic asthma, insect vein allergy). The exact mechanisms by which efficiency is achieved are currently unknown. Immunotherapy can be performed subcutaneously (SCIT) and sublingually (SLIT). Significant progress has been made in terms of AIT efficiency and security.
References
Grammer LC, Harris KE. Principles of immunologic management of allergic diseases due to extrinsic antigens. In: Grammer LC, Greenberger PA, editors. Patterson’s allergic diseases. 8th ed. Philadelphia: Wolters Kluwer, 2018; p. 239–249.
Berings M, Karaaslan C, Altunbulakli C, Gevaert P, Akdis M, Bachert C, et al. Advances and highlights in allergen immunotherapy: on the way to sustained clinical and immunologic tolerance. J Allergy Clin Immunol. 2017; 140:1250–1267.
Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011; 127:S1–S55.
Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy. 2001; 31:1392–1397.
Nelson HS. Injection immunotherapy for inhalant allergens. In: Adkinson NF Jr, Bochner BS, Burk AW, Busse WW, Holgate ST, Lemanske RF, et al, editors. Middleton’s allergy principles and practice. 8th ed. Philadelphia: Elsevier/Saunders, 2014; p. 1416– 1437.
Radtke M, Grammer LC. Subcutaneous administration of allergen vaccines. In: Lockey RF, Ledford DK, editors. Allergens and allergen immunotherapy. 4th ed., revised and expanded. New York: Marcel Dekker, 2008; p. 321–332.
Durham SR, Walker SM, Varga EM, Jacobson MR, O’Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999; 341:468–475.
Greenhawt M, Oppenheimer J, Nelson M, Nelson H, Lockey R, Lieberman P, et al. Sublingual immunotherapy: a focused allergen immunotherapy practice parameter update. Ann Allergy Asthma Immunol. 2017; 118:276–282.e2.
O’Hehir RE, Sandrini A, Frew AJ. Sublingual immunotherapy for inhalant allergens. In: Adkinson NF Jr, Bochner BS, Burk AW, Busse WW, Holgate ST, Lemanske RF, et al, editors. Middleton’s allergy principles and practice. 8th ed. Philadelphia: Elsevier/Saunders, 2014; p. 1438–1446.
Asamoah F, Kakourou A, Dhami S, Lau S, Agache I, Muraro A, et al. Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews. Clin Transl Allergy. 2017; 7:25.
Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI Guidelines on Allergen Immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018; 73:765–798.
Gernez Y, Nowak-We˛grzyn A. Immunotherapy for food allergy: are we there yet? J Allergy Clin Immunol Pract. 2017; 5:250–272.
Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D, et al. Food allergy: a practice parameter update-2014. J Allergy Clin Immunol. 2014; 134:1016–1025.e43
